# Lionsgate Studios Corp.: financial statements, quarterly

LION · NYSE · CIK 2052959 · [Communication](/sectors/communication.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/lion.md) · [Financials](/companies/lion/financials.md) · [Filings](/companies/lion/filings.md) · [Insiders](/companies/lion/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/lion/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [487](/filings/0002052959-25-000018.md) | [604](/filings/0002052959-25-000044.md) | [628](/filings/0002052959-26-000014.md) | [866 d](/filings/0002052959-26-000049.md) | [526](/filings/0002052959-26-000067.md) | [475](/filings/0002052959-25-000044.md) | [724](/filings/0002052959-26-000014.md) | [907 d](/filings/0002052959-26-000049.md) | [777](/filings/0002052959-26-000067.md) |
| Operating income | $m | [(22.5)](/filings/0002052959-25-000018.md) | [(101)](/filings/0002052959-25-000044.md) | [27.7](/filings/0002052959-26-000014.md) | [77.5 d](/filings/0002052959-26-000049.md) | [(10.6)](/filings/0002052959-26-000067.md) | [(46.0)](/filings/0002052959-25-000044.md) | [36.0](/filings/0002052959-26-000014.md) | [118 d](/filings/0002052959-26-000049.md) | [25.6](/filings/0002052959-26-000067.md) |
| Interest expense | $m | [63.5](/filings/0002052959-25-000018.md) | [67.9](/filings/0002052959-25-000044.md) | [63.7](/filings/0002052959-26-000014.md) | [66.6 d](/filings/0002052959-26-000049.md) | [68.7](/filings/0002052959-26-000067.md) | [67.3](/filings/0002052959-25-000044.md) | [65.0](/filings/0002052959-26-000014.md) | [58.8 d](/filings/0002052959-26-000049.md) | [56.9](/filings/0002052959-26-000067.md) |
| Income tax | $m | [5.6](/filings/0002052959-25-000018.md) | [3.9](/filings/0002052959-25-000044.md) | [4.3](/filings/0002052959-26-000014.md) | [3.4 d](/filings/0002052959-26-000049.md) | [6.4](/filings/0002052959-26-000067.md) | [1.8](/filings/0002052959-25-000044.md) | [6.7](/filings/0002052959-26-000014.md) | [1.3 d](/filings/0002052959-26-000049.md) | [7.8](/filings/0002052959-26-000067.md) |
| Net income | $m | [(59.4)](/filings/0002052959-25-000018.md) | [(163)](/filings/0002052959-25-000044.md) | [(21.9)](/filings/0002052959-26-000014.md) | [(117) d](/filings/0002052959-26-000049.md) | [(109)](/filings/0002052959-26-000067.md) | [(114)](/filings/0002052959-25-000044.md) | [(46.2)](/filings/0002052959-26-000014.md) | [70.2 d](/filings/0002052959-26-000049.md) | [(28.8)](/filings/0002052959-26-000067.md) |
| Diluted EPS | $ per share | [(0.24)](/filings/0002052959-25-000018.md) | [(0.66)](/filings/0002052959-25-000044.md) | [(0.09)](/filings/0002052959-26-000014.md) | not reported | [(0.40)](/filings/0002052959-26-000067.md) | [(0.39)](/filings/0002052959-25-000044.md) | [(0.16)](/filings/0002052959-26-000014.md) | not reported | [(0.10)](/filings/0002052959-26-000067.md) |
| Basic EPS | $ per share | [(0.24)](/filings/0002052959-25-000018.md) | [(0.66)](/filings/0002052959-25-000044.md) | [(0.09)](/filings/0002052959-26-000014.md) | not reported | [(0.40)](/filings/0002052959-26-000067.md) | [(0.39)](/filings/0002052959-25-000044.md) | [(0.16)](/filings/0002052959-26-000014.md) | not reported | [(0.10)](/filings/0002052959-26-000067.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2022-03-31) | period not labelled (2023-03-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | [277](/filings/0002052959-25-000010.md) | not reported | not reported | not reported | [213](/filings/0002052959-26-000049.md) | [186](/filings/0002052959-25-000018.md) | [202](/filings/0002052959-25-000044.md) | [182](/filings/0002052959-26-000014.md) | [342](/filings/0002052959-26-000067.md) | [426](/filings/0002052959-26-000067.md) |
| Current assets | $m | not reported | not reported | [1,372](/filings/0002052959-25-000010.md) | not reported | not reported | not reported | [1,236](/filings/0002052959-26-000049.md) | [1,408](/filings/0002052959-25-000018.md) | [1,300](/filings/0002052959-25-000044.md) | [1,320](/filings/0002052959-26-000014.md) | [1,489](/filings/0002052959-26-000067.md) | [1,458](/filings/0002052959-26-000067.md) |
| Total assets | $m | not reported | not reported | [5,103](/filings/0002052959-25-000010.md) | not reported | not reported | not reported | [6,822](/filings/0002052959-26-000049.md) | [5,161](/filings/0002052959-25-000018.md) | [5,159](/filings/0002052959-25-000044.md) | [5,244](/filings/0002052959-26-000014.md) | [5,327](/filings/0002052959-26-000067.md) | [5,333](/filings/0002052959-26-000067.md) |
| Current liabilities | $m | not reported | not reported | [3,642](/filings/0002052959-25-000010.md) | not reported | not reported | not reported | [3,467](/filings/0002052959-26-000049.md) | [3,129](/filings/0002052959-25-000018.md) | [2,816](/filings/0002052959-25-000044.md) | [2,869](/filings/0002052959-26-000014.md) | [3,047](/filings/0002052959-26-000067.md) | [3,321](/filings/0002052959-26-000067.md) |
| Total liabilities | $m | not reported | not reported | [6,130](/filings/0002052959-25-000010.md) | not reported | not reported | not reported | [7,081](/filings/0002052959-26-000049.md) | [6,164](/filings/0002052959-25-000018.md) | [6,276](/filings/0002052959-25-000044.md) | [6,376](/filings/0002052959-26-000014.md) | [6,377](/filings/0002052959-26-000067.md) | [6,391](/filings/0002052959-26-000067.md) |
| Long-term debt | $m | not reported | not reported | [923](/filings/0002052959-25-000010.md) | not reported | not reported | not reported | [1,839](/filings/0002052959-26-000049.md) | [1,529](/filings/0002052959-25-000018.md) | [1,772](/filings/0002052959-25-000044.md) | [1,764](/filings/0002052959-26-000014.md) | [1,778](/filings/0002052959-26-000067.md) | [1,740](/filings/0002052959-26-000067.md) |
| Current portion of debt | $m | not reported | not reported | [860](/filings/0002052959-25-000010.md) | not reported | not reported | not reported | [134](/filings/0002052959-26-000049.md) | [137](/filings/0002052959-25-000018.md) | [159](/filings/0002052959-25-000044.md) | [159](/filings/0002052959-26-000014.md) | [162](/filings/0002052959-26-000067.md) | [162](/filings/0002052959-26-000067.md) |
| Shareholders' equity | $m | [(260)](/filings/0002052959-25-000010.md) | [786](/filings/0002052959-26-000049.md) | [(1,152)](/filings/0002052959-25-000010.md) | [(49.0)](/filings/0002052959-25-000044.md) | [(225)](/filings/0002052959-26-000014.md) | [(256)](/filings/0002052959-26-000014.md) | [(265)](/filings/0002052959-26-000049.md) | [(1,148)](/filings/0002052959-25-000018.md) | [(1,261)](/filings/0002052959-25-000044.md) | [(1,276)](/filings/0002052959-26-000014.md) | [(1,193)](/filings/0002052959-26-000067.md) | [(1,200)](/filings/0002052959-26-000067.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(159)](/filings/0002052959-25-000018.md) | [(82.0) d](/filings/0002052959-25-000044.md) | [(119) d](/filings/0002052959-26-000014.md) | [194 d](/filings/0002052959-26-000049.md) | [(31.0)](/filings/0002052959-26-000067.md) | [(104) d](/filings/0002052959-25-000044.md) | [(109) d](/filings/0002052959-26-000014.md) | [269 d](/filings/0002052959-26-000049.md) | [54.1](/filings/0002052959-26-000067.md) |
| Capital expenditure | $m | [4.1](/filings/0002052959-25-000018.md) | [4.5 d](/filings/0002052959-25-000044.md) | [1.3 d](/filings/0002052959-26-000014.md) | [3.6 d](/filings/0002052959-26-000049.md) | [3.5](/filings/0002052959-26-000067.md) | [3.2 d](/filings/0002052959-25-000044.md) | [3.0 d](/filings/0002052959-26-000014.md) | [3.7 d](/filings/0002052959-26-000049.md) | [2.9](/filings/0002052959-26-000067.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [246](/filings/0002052959-25-000018.md) | [249](/filings/0002052959-25-000044.md) | [250](/filings/0002052959-26-000014.md) | [272](/filings/0002052959-26-000067.md) | [289](/filings/0002052959-25-000044.md) | [290](/filings/0002052959-26-000014.md) | [292](/filings/0002052959-26-000067.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 297,559,680 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0002052959-26-000067.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.